Fedor Moiseenko
Impact in
-
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
-
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
- Oncology 32
- Colorectal Cancer Treatments and Studies 15
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 4
-
- Lung Cancer Treatments and Mutations 22
- Gastric Cancer Management and Outcomes 5
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Nikita Volkov (14 shared papers)Alexey Bogdanov (5 shared papers)Vladimir Moiseyenko (9 shared papers)Michael Dubina (3 shared papers)Victor Kolikov (1 shared paper)Е. А. Филиппова (6 shared papers)D. Ross Camidge (4 shared papers)Jair Bar (5 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Annals of Oncology (6 papers)Journal of Thoracic Oncology (3 papers)Cancer Research (2 papers)Biology Direct (1 paper)
- Partner nations
- RussiaUnited StatesFrance
In The Last Decade
Fedor Moiseenko
50 papers receiving 418 citations
Peers
Comparison fields: 5 of 65
- Oncology 138
- Cancer Research 76
- Pulmonary and Respiratory Medicine 147
- Hepatology 26
- Biomaterials 30
Countries citing papers authored by Fedor Moiseenko
This map shows the geographic impact of Fedor Moiseenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fedor Moiseenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fedor Moiseenko more than expected).
Fields of papers citing papers by Fedor Moiseenko
This network shows the impact of papers produced by Fedor Moiseenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fedor Moiseenko. The network helps show where Fedor Moiseenko may publish in the future.
Co-authors
The 25 scholars most cited alongside Fedor Moiseenko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 118 | |
| 2 | 2022 | 63 | |
| 3 | 2008 | 56 | |
| 4 | 2019 | 27 | |
| 5 | 2016 | 24 | |
| 6 | 2022 | 22 | |
| 7 | 2024 | 10 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 9 | |
| 10 | 2022 | 9 | |
| 11 | 2024 | 8 | |
| 12 | 2022 | 6 | |
| 13 | 2021 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2022 | 4 | |
| 16 | 2022 | 4 | |
| 17 | [Effectiveness of gefitinib (Iressa) as first-line therapy for inoperable non-small-cell lung cancer with mutated EGFR gene (phase II study)]. | 2010 | 4 |
| 18 | 2021 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2021 | 2 |
About Fedor Moiseenko
Fedor Moiseenko is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 64 papers that have together received 428 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (22 papers), Colorectal Cancer Treatments and Studies (15 papers), Cancer Immunotherapy and Biomarkers (6 papers), Gastric Cancer Management and Outcomes (5 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Oncology (138 citations), Cancer Research (76 citations), Pulmonary and Respiratory Medicine (147 citations), Hepatology (26 citations) and Biomaterials (30 citations). Fedor Moiseenko has collaborated with scholars based in Russia, United States and France. Frequent co-authors include Nikita Volkov, Alexey Bogdanov, Vladimir Moiseyenko, Michael Dubina, Victor Kolikov, Е. А. Филиппова, D. Ross Camidge, Jair Bar, Hidehito Horinouchi and Pascale Tomasini. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Cancer Research and Biology Direct.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.